Risk factors associated with early mortality in patients with multiple myeloma who were treated upfront with a novel agents containing regimen

BACKGROUND: Although the introduction of novel agents improved the survival outcomes in patients with multiple myeloma (MM), some patients died within one year (early mortality, EM) following diagnosis. In this study, we evaluated the EM rate, and investigated the risk factors associated with EM in...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Cancer
Main Authors: Jung, Sung-Hoon, Cho, Min-Seok, Kim, Hee Kyung, Kim, Seok Jin, Kim, Kihyun, Cheong, June-Won, Kim, Soo-Jeoong, Kim, Jin Seok, Ahn, Jae-Sook, Kim, Yeo-Kyeoung, Yang, Deok-Hwan, Kim, Hyeoung-Joon, Lee, Je-Jung
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2016
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4977683/
https://ncbi.nlm.nih.gov/pubmed/27501959
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-016-2645-y
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados